To further investigate the antagonism of the antiproliferative effects of TNF-α by RASSF1C, we assessed the activation of caspase 3/7 in breast and lung cancer cells overexpressing RASSF1A and RASSF1C that were treated with TNF-α. The gene discussed is CASP3; the disease is lung carcinoma.